3//SEC Filing
Longevity Fund 2 LP 3
Accession 0001209191-21-009907
CIK 0001656536other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 7:31 PM ET
Size
8.4 KB
Accession
0001209191-21-009907
Insider Transaction Report
Form 3
Longevity Fund 2 LP
10% Owner
Holdings
Convertible Series C Preferred Stock
→ Common Stock (79,143 underlying)
Footnotes (1)
- [F1]The Convertible Series C Preferred Stock is convertible into the issuer's common stock on a 12.6352-for-1 basis and has no expiration date. It will automatically convert into common stock upon the closing of the issuer's initial public offering.
Issuer
Decibel Therapeutics, Inc.
CIK 0001656536
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001708655
Filing Metadata
- Form type
- 3
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 7:31 PM ET
- Size
- 8.4 KB